… as J&J Innovative Medicine, guilty of violating both … lipids detailed in the drug’s FDA-approved label. The plaintiffs … Intelence was safe and effective for once-daily dosing and in treatment … products. The evidence at trial also demonstrated that Janssen …

… HIV drug marketing case involving the marketing of Prezista and Intelence … such as Medicare, Medicaid and the AIDS Drug Assistance Program. … a new trial, saying the verdict … FDA-approved label. The plaintiffs also claimed that Janssen compensated doctors …

… for illegally promoting the HIV drugs Prezista and Intelence. U.S. … to programs such as Medicare, Medicaid and the AIDS Drug Assistance Program. Quraishi … a six-week trial. Janssen had sought a … said Janssen paid doctors to promote the drugs at dinner and …

… and are virologically suppressed (HIV-1 RNA less than 50 … and Postpartum Human Data Intelence Label Pifeltro doravirine 100 mg … available for the approved treatment dose of 600 mg … CD4-directed post-attachment HIV-1 inhibitor Intravenous Injection …

… HIV drugs, such as: cobicistat (Tybost) nelfinavir (Viracept) ritonavir (Norvir) certain antidepressants … HIV drugs, such as: efavirenz etravirine (Intelence) certain cancer drugs, … drugs, talk with your doctor about your treatment options. If your doctor …

… taking Intelence together with other HIV medicines had undetectable levels of HIV, compared … placebo (a dummy treatment) plus the other HIV medicines. These findings were … of treatment. After 48 weeks of taking Intelence together with other HIV medicines, …

… of two of its HIV/AIDS-treatment drugs, in violation of … government for its drugs, Prezista and Intelence, and awarded … against the billion-dollar pharmaceutical company Janssen. In 2012 … and Drug Administration (FDA) and for uses not medically reasonable …

… promotion of the HIV drugs Prezista and Intelence. Janssen hired two … during the six-week trial demonstrated that Janssen … submission of drug claims to Medicare, ADAP, and Medicaid for … drugs by promoting their use beyond their labels and misleading doctors …

… promotions of its HIV meds Prezista and Intelence. More specifically … J&J Innovative Medicine, was initially accused … dangerous contradiction from the drug’s FDA-approved label, which … Intelence was safe and effective for once-daily dosing and in treatment …

… despite the FDA-approved label stating that the drug created serious adverse … Intelence drug was safe and effective for once-a-day use for HIV … Medicare and U.S. taxpayers." The Reese Marketos trial … that specializes in high-stakes trials. The firm's …